The AstraZeneca-Oxford vaccine candidate deal has progressed to Phase-III trials and their Covidshield vaccine is getting government permission to manufacture the immunisation.
from The Financial Express https://ift.tt/3aSD9Ax
Monday, 24 August 2020
Covid vaccine boost: Serum Institute founder adds $3.6 billion to his wealth in just under 4 months
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment